首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of cancer

缩写:J CANCER

ISSN:1837-9664

e-ISSN:1837-9664

IF/分区:3.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引5574
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yin-Che Lu,Kai-Liang Tang,Chih-Hsien Liao et al. Yin-Che Lu et al.
Head and neck cancer, particularly oral squamous cell carcinoma (OSCC), remains a major global health burden, with especially high incidence and mortality in Taiwan due to the widespread habit of betel quid chewing. Betel nut mediated OSCC ...
Shuo Wang,Changqing Yang,Xingkai Wang et al. Shuo Wang et al.
Background: N4-acetylcytidine (ac4C) RNA modification is a critical epitranscriptomic regulator of cancer progression, yet its specific biological functions and regulatory patterns in lung adenocarcinoma (LUAD) remain poo...
Chien-Chin Chen,Cheng-Lin Wu,Bo-Jiun Tzeng et al. Chien-Chin Chen et al.
Background: Diagnosing primary cutaneous T-cell lymphoma (PCTCL) relies on the comprehensive evaluation of clinical presentation, histopathology, immune profile, and molecular testing. Regarding molecular testing, the BIO...
Congcong Tang,Qi Tang,Siyuan Tang et al. Congcong Tang et al.
Under physiological conditions, tsRNAs regulate mRNA transcription, reverse transcription, and protein translation to mediate cell apoptosis, cell cycle, and epigenetic regulation. Pathogenic tsRNAs are disease-specific or disease-related t...
Amin Zhang,Hanyang Wu,Wancheng Liu et al. Amin Zhang et al.
The potential functional Single Nucleotide Polymorphism (SNPs) of DNA Damage Response (DDR)-related genes may influence AML aggressiveness and clinical outcomes through regulating genomic stability. However, systematic evaluation of functio...
Jingwen Si,Hanbo Li,Han Zhang et al. Jingwen Si et al.
Background: Ovarian cancer (OV) is characterized by pronounced intratumoral heterogeneity and unfavorable clinical outcomes, yet clinically applicable biomarkers for risk stratification remain limited. Although bulk trans...
Tianci Wang,Fei Han,Yuxuan She et al. Tianci Wang et al.
Purpose: Head and neck cancer ranks as the seventh most common type of cancer worldwide. For patients diagnosed at advanced stages, the five-year survival rate remains below 40%, underscoring the urgent need for early det...
Yi-Hsun Lee,Pei-Ni Chen,Yi-Hsien Hsieh et al. Yi-Hsun Lee et al.
Empagliflozin is a sodium-glucose cotransporter 2 inhibitor widely prescribed for the treatment of type 2 diabetes mellitus. It promotes urinary glucose excretion by inhibiting renal glucose reabsorption. Although empagliflozin has been wid...
Xiaozheng Ou,Jinghong Xu,Yuting Jin et al. Xiaozheng Ou et al.
Purpose: Drug resistance in colorectal cancer (CRC) necessitates novel therapeutic strategies. This study investigated whether arteannuin B, a sesquiterpene lactone from Artemisia annua, induces ferroptosis in CRC cells a...
Hao Ling,Yanzhu Hu Hao Ling
Background: Hepatocellular carcinoma (HCC) continues to impose a heavy global health burden, with high incidence and mortality. The disease is highly heterogeneous and is commonly detected at late stages, which compromise...